FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is kicking off phase two of its 21st Century GMP initiative using new authorities and funding under the FDA Safety & Innovation Act. To encourage investment in quality manufacturing systems, the agency is highlighting the cost savings seen by early adopters of quality systems..
You may also be interested in...
FDA Warning On Data Integrity: “Sometimes Lawyers Become Too Clever For Their Own Good”
How companies handle manufacturing troubles may be more important to the agency than that they happen, top FDA officials indicate, warning that a damaged relationship can affect all of a firm’s interactions with FDA.
FDA Warning On Data Integrity: “Sometimes Lawyers Become Too Clever For Their Own Good”
How companies handle manufacturing troubles may be more important to the agency than that they happen, top FDA officials indicate, warning that a damaged relationship can affect all of a firm’s interactions with FDA.
FDA Warning On Data Integrity: “Sometimes Lawyers Become Too Clever For Their Own Good”
How companies handle manufacturing troubles may be more important to the agency than that they happen, top FDA officials indicate, warning that a damaged relationship can affect all of a firm’s interactions with FDA.